Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Rader

Showing results (61-70 of 150) with videos related to

Pageof 15
Sort By:
Biochemistry|April 17, 2015
Lipid-directed vinculin dimerizationKrishna Chinthalapudi, Dipak N Patil, Erumbi S Rangarajan, et al.
Bioconjugate Chemistry|August 8, 2014
Improving the serum stability of site-specific antibody conjugates with sulfone linkersJames T Patterson, Shigehiro Asano, Xiuling Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalystChristoph Rader, Subhash C Sinha, Mikhail Popkov, et al.
Plos One|April 25, 2014
Selection of apoptotic cell specific human antibodies from adult bone marrowCaroline Grönwall, Edgar D Charles, Lynn B Dustin, et al.
Plos One|June 24, 2011
Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignanciesJiahui Yang, Sivasubramanian Baskar, Ka Yin Kwong, et al.
Antibody Therapeutics|January 14, 2020
Dual-mechanistic antibody-drug conjugate <i>via</i> site-specific selenocysteine/cysteine conjugationNapon Nilchan, Xiuling Li, Lee Pedzisa, et al.
Bioconjugate Chemistry|May 18, 2022
Sculpting a Uniquely Reactive Cysteine Residue for Site-Specific Antibody ConjugationDobeen Hwang, Napon Nilchan, HaJeung Park, et al.
Oncogene|July 21, 2022
ROR1-targeting switchable CAR-T cells for cancer therapyHaiyong Peng, Thomas Nerreter, Katrin Mestermann, et al.
Oncogene|February 21, 2024
Correction: ROR1-targeting switchable CAR-T cells for cancer therapyHaiyong Peng, Thomas Nerreter, Katrin Mestermann, et al.
Bioorganic & Medicinal Chemistry|April 21, 2016
Engineered production of cancer targeting peptide (CTP)-containing C-1027 in Streptomyces globisporus and biological evaluationWenli Li, Xiuling Li, Tingting Huang, et al.
Pageof 15

Showing results (61-70 of 150) with videos related to

Sort By:
Pageof 15
Biochemistry|April 17, 2015
Lipid-directed vinculin dimerizationKrishna Chinthalapudi, Dipak N Patil, Erumbi S Rangarajan, et al.
Bioconjugate Chemistry|August 8, 2014
Improving the serum stability of site-specific antibody conjugates with sulfone linkersJames T Patterson, Shigehiro Asano, Xiuling Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalystChristoph Rader, Subhash C Sinha, Mikhail Popkov, et al.
Plos One|April 25, 2014
Selection of apoptotic cell specific human antibodies from adult bone marrowCaroline Grönwall, Edgar D Charles, Lynn B Dustin, et al.
Plos One|June 24, 2011
Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignanciesJiahui Yang, Sivasubramanian Baskar, Ka Yin Kwong, et al.
Antibody Therapeutics|January 14, 2020
Dual-mechanistic antibody-drug conjugate <i>via</i> site-specific selenocysteine/cysteine conjugationNapon Nilchan, Xiuling Li, Lee Pedzisa, et al.
Bioconjugate Chemistry|May 18, 2022
Sculpting a Uniquely Reactive Cysteine Residue for Site-Specific Antibody ConjugationDobeen Hwang, Napon Nilchan, HaJeung Park, et al.
Oncogene|July 21, 2022
ROR1-targeting switchable CAR-T cells for cancer therapyHaiyong Peng, Thomas Nerreter, Katrin Mestermann, et al.
Oncogene|February 21, 2024
Correction: ROR1-targeting switchable CAR-T cells for cancer therapyHaiyong Peng, Thomas Nerreter, Katrin Mestermann, et al.
Bioorganic & Medicinal Chemistry|April 21, 2016
Engineered production of cancer targeting peptide (CTP)-containing C-1027 in Streptomyces globisporus and biological evaluationWenli Li, Xiuling Li, Tingting Huang, et al.
Pageof 15